BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 1185590)

  • 21. Angiotensin II and renal excretion of sodium and potassium in unanaesthetized dogs.
    Børresen HC; Rørvik S; Guldvog I; Aakvaag A
    Scand J Clin Lab Invest; 1982 Feb; 42(1):87-92. PubMed ID: 7134792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.
    Kimbrough HM; Vaughan ED; Carey RM; Ayers CR
    Circ Res; 1977 Feb; 40(2):174-8. PubMed ID: 191213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of renal function by intrarenal angiotensin II.
    Levens NR; Freedlender AE; Peach MJ; Carey RM
    Endocrinology; 1983 Jan; 112(1):43-9. PubMed ID: 6847833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Escape from the sodium-retaining action of intrarenal angiotensins II and III in the conscious dog.
    Dickstein GM; Woodson JF; Lamb NE; Rose CE; Peach MJ; Carey RM
    Endocrinology; 1985 Nov; 117(5):2160-9. PubMed ID: 4042980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms regulating renin release in dogs with thoracic caval constriction.
    Witty RT; Davis JO; Shade RE; Johnson JA; Prewitt RL
    Circ Res; 1972 Sep; 31(3):339-47. PubMed ID: 4341468
    [No Abstract]   [Full Text] [Related]  

  • 26. Renal vascular responses to infusions of 1-sarcosine-8-alanine-angiotensin II (saralasin) in man and dog [proceedings].
    Lewis PS; Wilcox CS
    J Physiol; 1978 Jul; 280():42P-43P. PubMed ID: 690897
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of indomethacin, renal denervation, and propranolol on plasma renin activity in conscious dogs with chronic thoracic caval constriction.
    Echtenkamp SF; Davis JO; DeForrest JM; Rowe BP; Freeman RH; Seymour AA; Dietz JR
    Circ Res; 1981 Aug; 49(2):492-500. PubMed ID: 7018734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of angiotensin II blockade to study adrenal steroid secretion.
    Davis JO; Freeman RH
    Fed Proc; 1976 Nov; 35(13):2508-11. PubMed ID: 976493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure to demonstrate a humoral mechanism in the antinatriuresis of acute caval constriction.
    Kaloyanides GJ; Azer M
    J Clin Invest; 1972 May; 51(5):1297-300. PubMed ID: 5020437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal response to atrial natriuretic factor in conscious dogs with caval constriction.
    Freeman RH; Davis JO; Vari RC
    Am J Physiol; 1985 Apr; 248(4 Pt 2):R495-500. PubMed ID: 3157329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of angiotensin II and 1-Sar-8-Ala-angiotensin II on the renal function in sodium-replete and -deplete dogs [proceedings].
    Lijnen PJ; Fagard RH; Amery AK
    Arch Int Physiol Biochim; 1979 Feb; 87(1):193-4. PubMed ID: 92269
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of diltiazem hydrochloride upon sodium diuresis and renal function in chronic congestive heart failure.
    Kinoshita M; Kusukawa R; Shimono Y; Motomura M; Tomonaga G; Hoshino T
    Arzneimittelforschung; 1979; 29(4):676-81. PubMed ID: 582767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenergic blockade and renal hemodynamics.
    McCombs PR; Berkowitz HD
    Surgery; 1976 Aug; 80(2):246-251. PubMed ID: 7845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of saralasin on renal function of the rat.
    Hofbauer KG; Bauereiss K; Zschiedrich H; Gross F
    Prog Biochem Pharmacol; 1976; 12():63-83. PubMed ID: 1019171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium excretion and intrarenal hemodynamics in thoracic inferior vena cava constriction.
    Crumb CK; Minuth AN; Flasterstein AH; Hebert CS; Eknoyan G; Martinez-Maldonado M; Suki WN
    Am J Physiol; 1977 Jun; 232(6):F507-12. PubMed ID: 879285
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiotensin. II. Important role in the maintenance of arterial blood pressure.
    Johnson JA; Davis JO
    Science; 1973 Mar; 179(4076):906-7. PubMed ID: 4347166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs.
    Freeman RH; Davis JO; Williams GM; DeForrest JM; Seymour AA; Rowe BP
    Circ Res; 1979 Oct; 45(4):540-5. PubMed ID: 225056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrarenal effects of the renin-angiotensin system.
    Ploth DW; Navar LG
    Fed Proc; 1979 Aug; 38(9):2280-5. PubMed ID: 456614
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors affecting renal cortical blood flow. A review.
    Carriére S
    Can J Physiol Pharmacol; 1975 Feb; 53(1):1-20. PubMed ID: 1095165
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.